['DIGOXIN CONCENTRATIONS INCREASED > 50%', '', 'DIGOXIN SERUM CONCENTRATION INCREASE', 'DIGOXIN AUC INCREASE', 'RECOMMENDATIONS', 'AMIODARONE', '70%', 'NA', 'MEASURE SERUM DIGOXIN CONCENTRATIONS BEFORE INITIATING CONCOMITANT DRUGS. REDUCE DIGOXIN DOSE BY APPROXIMATELY 30% TO 50% AND CONTINUE MONITORING.', 'CAPTOPRIL', '58%', '39%', 'NITRENDIPINE', '57%', '15%', 'PROPAFENONE', '35-85%', 'NA', 'QUINIDINE', '100%', 'NA', 'RANOLAZINE', '87%', '88%', 'RITONAVIR', 'NA', '86%', 'VERAPAMIL', '50-75%', 'NA', 'DIGOXIN CONCENTRATIONS INCREASED < 50%', 'CARVEDILOL', '16%', '14%', 'MEASURE SERUM DIGOXIN CONCENTRATIONS BEFORE INITIATING CONCOMITANT DRUGS. REDUCE DIGOXIN DOSE BY APPROXIMATELY 15% TO 30% AND CONTINUE MONITORING.', 'DILTIAZEM', '20%', 'NA', 'NIFEDIPINE', '45%', 'NA', 'RABEPRAZOLE', '29%', '19%', 'TELMISARTAN', '20%', 'NA', 'DIGOXIN CONCENTRATIONS INCREASED, BUT MAGNITUDE IS UNCLEAR', 'ALPRAZOLAM, AZITHROMYCIN, CLARITHROMYCIN, CYCLOSPORINE, DICLOFENAC, DIPHENOXYLATE, EPOPROSTENOL, ERYTHROMYCIN, ESOMEPRAZOLE, INDOMETHACIN, ITRACONAZOLE, KETOCONAZOLE, LANSOPRAZOLE, METFORMIN, OMEPRAZOLE, PROPANTHELINE, SPIRONOLACTONE, TETRACYCLINE', 'MEASURE SERUM DIGOXIN CONCENTRATIONS BEFORE INITIATING CONCOMITANT DRUGS. CONTINUE MONITORING AND REDUCE DIGOXIN DOSE AS NECESSARY.', 'DIGOXIN CONCENTRATIONS DECREASED', 'ACARBOSE, ACTIVATED CHARCOAL, ALBUTEROL, ANTACIDS, ANTI-CANCER DRUGS, CHOLESTYRAMINE, COLESTIPOL, EXENATIDE, KAOLIN-PECTIN, MEALS HIGH IN BRAN, METOCLOPRAMIDE, MIGLITOL, NEOMYCIN, RIFAMPIN, SALBUTAMOL, ST. JOHN\xe2\x80\x99S WORT, SUCRALFATE, SULFASALAZINE', 'MEASURE SERUM DIGOXIN CONCENTRATIONS BEFORE INITIATING CONCOMITANT DRUGS. CONTINUE MONITORING AND INCREASE DIGOXIN DOSE BY APPROXIMATELY 20% TO 40% AS NECESSARY.', 'NO SIGNIFICANT DIGOXIN CONCENTRATIONS CHANGES', 'PLEASE REFER TO SECTION 12.3 FOR A COMPLETE LIST OF DRUGS WHICH WERE STUDIED BUT REPORTED NO SIGNIFICANT CHANGES ON DIGOXIN EXPOSURE.', 'NO ADDITIONAL ACTIONS ARE REQUIRED.']